BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24372482)

  • 1. Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A.
    Coimbra S; Oliveira H; Neuparth MJ; Figueiredo A; Rocha-Pereira P; Santos-Silva A
    Int J Dermatol; 2014 Mar; 53(3):393-6. PubMed ID: 24372482
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
    Alshiyab D; Chin MF; Edwards C; Anstey AV
    Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoralen plus ultraviolet A light phototherapy effectiveness.
    Feldman SR
    J Am Acad Dermatol; 2010 Oct; 63(4):718. PubMed ID: 20846573
    [No Abstract]   [Full Text] [Related]  

  • 4. Phototherapy in childhood.
    Ersoy-Evans S; Altaykan A; Sahin S; Kölemen F
    Pediatr Dermatol; 2008; 25(6):599-605. PubMed ID: 19067863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen and ultraviolet a light therapy for psoriasis.
    Stern RS
    N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of short-term psoralen and ultraviolet A light maintenance treatment to prevent early relapse in patients with chronic recurring plaque-type psoriasis.
    Radakovic S; Seeber A; Hönigsmann H; Tanew A
    Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):90-3. PubMed ID: 19292785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
    Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
    Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B in psoriasis: a comparison of clinical outcome and effect on circulating T-helper and T-suppressor/cytotoxic cells.
    Salem SA; Barakat MA; Morcos CM
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):235-42. PubMed ID: 20831697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photochemotherapy with psoralen and long-wave ultraviolet light. 1 1/2 year of experience of 2 dermatologic department in Tromsø].
    Kavli G
    Tidsskr Nor Laegeforen; 1978 Feb; 98(5):269-70. PubMed ID: 628923
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoralen photochemotherapy.
    McClelland PB; Morgan P; Leach EE; Shelk J
    Dermatol Nurs; 1997 Dec; 9(6):403-15; quiz 416-7. PubMed ID: 9460332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bath psoralen plus ultraviolet A for hidradenitis suppurativa: a review of 13 patients.
    Shareef M; Dawe R
    Br J Dermatol; 2011 Apr; 164(4):895-6. PubMed ID: 21166664
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of comparing effectiveness sine comparative effectiveness.
    Katz KA; Garner S
    J Am Acad Dermatol; 2010 Oct; 63(4):716-7; author reply 717. PubMed ID: 20846570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and histological evaluation of oral psoralen plus UV-A exposure (PUVA) for treating psoriasis vulgaris (author's transl)].
    Jimbow K; Nishio C; Uesugi T; Katoh M; Kato M; Makita A; Chiba M; Horikoshi T
    Nihon Hifuka Gakkai Zasshi; 1978; 88(1):23-36. PubMed ID: 306462
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrastructure study of hair damage after ultraviolet irradiation.
    Zuel-Fakkar NM; El Khateeb EA; Cousha HS; Hamed DM
    J Cosmet Dermatol; 2013 Dec; 12(4):254-60. PubMed ID: 24305423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
    Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
    Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
    Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A.
    Gleeson CM; Morar N; Staveley I; Bunker CB
    Br J Dermatol; 2011 Apr; 164(4):892-4. PubMed ID: 21143466
    [No Abstract]   [Full Text] [Related]  

  • 20. Poor metrics and lost opportunity.
    Stern RS
    J Am Acad Dermatol; 2010 Oct; 63(4):718-9. PubMed ID: 20846572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.